A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine

Clinical trial NCT00343681 · COMPLETED

Trial details

NCT number: NCT00343681
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza Orthomyxoviridae Infections

Start date: 2006-07-01
Primary completion: 2007-08-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.